Judith Maxwell Silverman

Program Officer, Vaccine Development & Surveillance - Chemistry, Manufacturing & Controls @ Bill & Melinda Gates Foundation

Dr. Silverman is an immunologist by training and has spent the majority of her career working in the Global health space.  Her PhD in microbiology & immunology focused on cellular mechanisms enabling immune evasion by leishmania parasites. Next she investigated the molecular etiology of template-directed proteopathies as a Post-Doc and then Faculty Researcher at the University of British Columbia (Vancouver, BC). In 2019 she joined the Bill & Melinda Gates Medical Research Institute working to translate cutting edge vaccine discovery work supported by the Bill & Melinda Gates Foundation into top-notch development programs at the Institute. She joined the Gates Foundation in June of 2022, where she works on the Vaccine Development, Chemistry Manufacturing and Controls team managing investments in new vaccine formulation technologies.